Generative AI now enables the design of novel viruses with specific biological properties. Current oversight fails to keep pace with these capabilities, creating gaps in biosecurity. Scientific American warns that this regulatory lag increases the risk of accidental or intentional misuse. Practitioners must now implement stricter screening protocols for synthetic DNA orders to mitigate these threats.